Abstract:Diffuse hemispheric gliomas (DHGs) account for 30% of aggressive cerebral tumors in children and young adults, exhibiting abysmal outcomes. Co-existing recurrent mutations in H3.3 histones at residue G34 (H3.3-G34R/V mutation) and concurrent inactivating mutations in TP53 and α-thalassemia/intellectual disability-X-linked gene (ATRX) implicate a coordinated molecular effort to drive oncogenesis. ATRX, a core component of the SWItch/Sucrose Non-Fermentable chromatin remodeling complex, regulates the incorporation of histone H3.3 into chromatin sites across the genome to maintain epigenome integrity. Yet, it is unclear how ATRX loss combines with H3.3-G34R/V mutations to influence cellular phenotype and dysregulate neuro-developmental programs. We propose that ATRX deficiency coordinates with key oncogenic partners by inducing oncogenic transcriptional programs and neuro-developmental pathways in DHGs. To investigate this, we employed CRISPR-editing to model H3.3-G34R followed by ATRX knockdown (ATRX-KD) in a TP53 mutant (TP53-mut) human-induced pluripotent stem cell (h-iPSC) line, developing an isogenic system to map contributions to epigenetic dysfunction made by specific molecular alterations. Upon differentiation of our h-iPSCs to neural stem cells (NSCs), we found unique transcriptional profiles associated with each genetic alteration, with upregulation of forebrain progenitor genes driven by ATRX-loss. Hierarchal clustering of normalized transcript counts revealed gene signatures from each model driving unique functional pathways, with the ATRX-KD and the triple mutant (TP53-mut, ATRX-KD, H3.3-G34R) signatures enriched for neural development pathways. Additionally, both signatures were associated with published transcriptional profiles of G34-mutant DHGs, emphasizing the disease relevance of our models. Further, time-course analysis using cerebral organoids uncovered distinct morphological changes with each alteration, with the triple mutant exhibiting impaired differentiation at later time points. These latter findings suggest that ATRX deficiency transcriptionally influences early neuronal differentiation, effects further refined by H3.3-G34 mutation. To conclude, our innovative models demonstrate the involvement of ATRX in neuro-developmental and differentiation phenotypes, illuminating underlying molecular features of aggressive DHGs.

The loss of ATRX/DAXX complex disturbs rDNA heterochromatinization and promotes development of glioma

ATRX Tolerates Activity-Dependent Histone H3 Methyl/phos Switching to Maintain Repetitive Element Silencing in Neurons.

The Daxx/Atrx Complex Protects Tandem Repetitive Elements During DNA Hypomethylation by Promoting H3K9 Trimethylation

ATRX Promotes Gene Expression by Facilitating Transcriptional Elongation Through Guanine-Rich Coding Regions.

Epco-21. Elucidating The Functional Relevance Of Atrx-Deficiency In H3.3-G34-Mutant Diffuse Hemispheric Glioma

DAXX-ATRX regulation of p53 chromatin binding and DNA damage response

Epco-25. Transposable Elements Induce Onco-Exaptation Events In Malignant Atrx-Deficient Gliomas

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma

A Potential Common Role of the Jumonji C Domain-Containing 1A Histone Demethylase and Chromatin Remodeler ATRX in Promoting Colon Cancer

A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.

The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin

Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells

ATRX Partners with Cohesin and MeCP2 and Contributes to Developmental Silencing of Imprinted Genes in the Brain

Cancer-associated DAXX mutations reveal a critical role for ATRX localization in ALT suppression

ATRX guards against aberrant differentiation in mesenchymal progenitor cells

DHX33 Recruits Gadd45a to Cause DNA Demethylation and Regulates a Subset of Gene Transcription.

DDX21 mediates co-transcriptional RNA m6A modification to promote transcription termination and genome stability

ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

DAXX in cancer: phenomena, processes, mechanisms and regulation

Autophagy deficiency activates rDNA transcription